Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.

Cynthia Feng

首页> 外文期刊>Digestive Diseases and Sciences >Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.

【24h】

Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.

机译：Quegley等：Quigley等：Quigley等：Quigley等，对“同时核糖酸赤羟糖酸戒烟和哀叹酸性酸引发后的黄疸发生和哀叹酸酸引发的丧失厌恶的发生”反应。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Digestive Diseases and Sciences》 |2018年第7期|共2页
作者
Cynthia Feng;
展开▼
作者单位

Medical Affairs Intercept Pharmaceuticals;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
专利

1. Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al. [J] . Cynthia Feng Digestive Diseases and Sciences . 2018,第7期

机译：Quegley等：Quigley等：Quigley等：Quigley等，对“同时核糖酸赤羟糖酸戒烟和哀叹酸性酸引发后的黄疸发生和哀叹酸酸引发的丧失厌恶的发生”反应。
2. Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review [J] . Li Xuan, Liao Min, Pan Qiong, European journal of gastroenterology and hepatology . 2020,第9期

机译：对原发性胆管炎患者嗜虫酸和熊甲酸核糖酸的联合治疗对熊科糖酸不完全反应的患者：系统审查
3. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid [J] . Hirschfield Gideon M., Mason Andrew, Luketic Velimir, Gastroenterology . 2015,第4期

机译：奥贝胆酸在原发性胆汁性肝硬化和对熊去氧胆酸反应不足的患者中的疗效
4. Dose Response of Ursodeoxycholic Acid in the Treatment of Cholestatic Disorders [C] . G. Mazzella, S. Liva, F. Ferrara, Falk Symposium . 2003

机译：核糖糖酸治疗胆汁淤积症的剂量反应
5. Defining the Dynamics Between the Gut Microbiota, Microbial Derived Secondary Bile Acid Ursodeoxycholic Acid (UDCA), and Clostridioides difficile Pathogenesis [D] . Winston, Jenessa Andrzejewski 2019

机译：定义肠道菌群，微生物衍生的次级胆汁酸熊去氧胆酸（UDCA）和艰难梭菌发病机理之间的动力学
6. Clarification of Obeticholic Acid Dosing: Response to Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation by Quigley et al. [O] . Cynthia Feng -1

机译：奥贝胆酸剂量的澄清：Quigley等人对熊去氧胆酸同时停用和奥贝胆酸引发后黄疸的发生的反应。
7. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid [O] . Hirschfield Gideon M., Mason Andrew, Luketic Velimir, 2015

机译：奥贝胆酸在原发性胆汁性肝硬化患者中的疗效及对熊去氧胆酸的反应不足
8. Developmental Toxicity and Structure-Activity Relationships of Aliphatic Acids, Including Dose-Response Assessment of Valproic Acid in Mice and Rats [R] . Narotsky, M. G., Francis, E. Z., Kavlock, R. J. 1994

机译：脂肪酸的发育毒性和构效关系，包括丙戊酸在小鼠和大鼠中的剂量反应评估

Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.

著录项

相似文献

相关主题

期刊订阅